Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: Are all CMFs alike?
- 1 May 1998
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 9 (5) , 489-493
- https://doi.org/10.1023/a:1008236502420
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Stopping Metastases at Their SourceNew England Journal of Medicine, 1997
- Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast CancerNew England Journal of Medicine, 1997
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.Journal of Clinical Oncology, 1997
- Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancerAnnals of Oncology, 1996
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Sequential or Alternating Doxorubicin and CMF Regimens in Breast Cancer With More Than Three Positive NodesJAMA, 1995
- The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-upAnnals of Oncology, 1994
- “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)European Journal of Cancer and Clinical Oncology, 1991
- Combination Chemotherapy as an Adjuvant Treatment in Operable Breast CancerNew England Journal of Medicine, 1976